Authors: | Rosenzweig, K. E.; Fox, J. L.; Giraud, P. |
Article Title: | Response to radiation |
Abstract: | Computed tomography (CT) has traditionally been the standard radiographic modality for diagnosing and monitoring non-small cell; lung cancer (NSCLC) after treatment. Given the limitations of CT, the utility of 18F-fluoro-2- deoxy-glucose positron emission tomography (FDG-PET) has been investigated for the management of NSCLC, with promising findings. Its adjunctive role with CT in diagnosing and staging disease is well established. FDG-PET also has been found to be a valuable tool for radiation treatment planning because it improves the precision of lesion definition. More recently, its value for determining clinical response both during and after treatment has been explored. This review highlights the various applications of FDG-PET in the diagnosis and management of NSCLC as corroborated by clinical data, with considerations of future directions. © 2004 Elsevier Inc. All rights reserved. |
Keywords: | cancer chemotherapy; cancer survival; treatment outcome; cancer surgery; disease course; review; cancer radiotherapy; cancer staging; positron emission tomography; antineoplastic agent; neoplasm staging; diagnostic accuracy; radiopharmaceuticals; computer assisted tomography; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; tomography, x-ray computed; patient monitoring; prediction; medical assessment; radiation response; carcinogenesis; correlation analysis; statistical significance; diagnostic value; quantitative analysis; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; data analysis; radioisotope; technique; tomography, emission-computed; humans; human; priority journal |
Journal Title: | Seminars in Radiation Oncology |
Volume: | 14 |
Issue: | 4 |
ISSN: | 1053-4296 |
Publisher: | Elsevier Inc. |
Date Published: | 2004-10-01 |
Start Page: | 322 |
End Page: | 325 |
Language: | English |
DOI: | 10.1016/j.semradonc.2004.06.002 |
PROVIDER: | scopus |
PUBMED: | 15558507 |
DOI/URL: | |
Notes: | Semin. Radiat. Oncol. -- Cited By (since 1996):3 -- Export Date: 16 June 2014 -- CODEN: SRONE -- Source: Scopus |